Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities. | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A17567 |
|---|---|
| Formula | C22H23ClN4O7S |
| Molecular Weight | 522.96 |
| CAS Number | 857890-39-2 |
| SMILES | O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC4CC4)=O)C(Cl)=C3)C2=C1)N.OS(=O)(C)=O |
| Synonyms | E7080 mesylate, E 7080, E-7080 |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 34 mg/mL (65.01 mM) | |
| Ethanol | <1 mg/mL | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 19.12 mL | 95.61 mL | 191.22 mL |
| 0.5 mM | 3.82 mL | 19.12 mL | 38.24 mL |
| 1 mM | 1.91 mL | 9.56 mL | 19.12 mL |
| 5 mM | 0.38 mL | 1.91 mL | 3.82 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
